Defining the relationship between COPD and CVD: what are the implications for clinical practice?

Area of Science:

• Pulmonary Medicine
• Cardiology
• Internal Medicine

Background:

• Cardiovascular diseases (CVDs) are significant comorbidities in chronic obstructive pulmonary disease (COPD).
• CVD presence in COPD patients correlates with higher hospitalization rates, longer hospital stays, and increased mortality.
• The economic impact of CVD in COPD is substantial, potentially exceeding COPD treatment costs.

Purpose of the Study:

• To review the prevalence, incidence, and underlying mechanisms of CVD in COPD.
• To discuss clinical implications and opportunities for improved CVD prevention and treatment in COPD patients.
• To advocate for enhanced CVD assessment and targeted interventions in specific COPD populations.

Main Methods:

• Literature review summarizing current knowledge on COPD and CVD.
• Analysis of biological mechanisms linking COPD and CVD.
• Discussion of clinical practice implications and evidence-based guidelines.

Main Results:

• CVDs are highly prevalent in COPD, significantly impacting patient prognosis and healthcare expenditure.
• Despite recognized significance, CVDs in COPD are often under-recognized and undertreated.
• Biological links between COPD and CVD are increasingly understood, yet clinical management lags.

Conclusions:

• Active assessment for cardiovascular conditions is recommended for all COPD patients.
• Targeted CVD screening and early intervention in individuals under 65 with COPD may yield the greatest benefits.
• Addressing institutional barriers and developing evidence-based guidelines are crucial for effective CVD management in COPD.